Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
1997-1-31
pubmed:abstractText
Flow cytometry was used to study phagocytic function (uptake of fluorescein isothiocyanate-labeled bacteria) and release of reactive oxygen products (dihydrorhodamine 123 converted to rhodamine 123) following phagocytosis by neutrophil granulocytes of heparinized whole blood treated with adrenaline, noradrenaline, dopamine, dobutamine, or orciprenaline. Reduced neutrophil phagocytosis and reactive oxygen production were seen at 12 micrograms of adrenaline per liter (72% each compared with control values); at 120 micrograms of noradrenaline (72% each), dobutamine (83 and 80%, respectively), and orciprenaline (81 and 80%, respectively) per liter; and at 100 micrograms of dopamine per liter (66 and 70%) (P < 0.05 for all). At these dosages, neutrophil chemotaxis was reduced to < 50% of control values for all catecholamines. Treatment with catecholamines at lower dosages had no significant effect on phagocytosis or generation of reactive oxygen products or chemotaxis. The phagocytic capacity of granulocytes was related to the generation of reactive oxygen products (r = 0.789; P < 0.05). The results demonstrate that catecholamines have a suppressive effect on the response of phagocytic cells to bacterial pathogens at high therapeutic levels in blood.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-1323612, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-1324014, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-1350291, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-165364, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-2166759, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-2474025, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-2536474, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-2893597, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-3257980, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-4356150, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-5778389, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-7319991, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-7697538, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-7793871, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-8026191, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-8026194, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-8118041, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-8168970, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-8386998, http://linkedlifedata.com/resource/pubmed/commentcorrection/8807207-8985651
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1071-412X
pubmed:author
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
423-8
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1996
pubmed:articleTitle
High-dose catecholamine treatment decreases polymorphonuclear leukocyte phagocytic capacity and reactive oxygen production.
pubmed:affiliation
Department of Infectious Diseases, University Hospital of Vienna, Austria.
pubmed:publicationType
Journal Article